• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有心肌梗死病史患者的纤溶实验室评估。

Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.

作者信息

Chandler W L, Stratton J R

机构信息

Department of Laboratory Medicine, University of Washington, Seattle 98195.

出版信息

Am J Clin Pathol. 1994 Aug;102(2):248-52. doi: 10.1093/ajcp/102.2.248.

DOI:10.1093/ajcp/102.2.248
PMID:8042597
Abstract

The aims of this study were to determine whether elevated plasminogen activator inhibitor type 1 (PAI-1) activity after myocardial infarction reflects baseline PAI-1 or represents an acute-phase response secondary to the infarction, and to determine how tissue plasminogen activator (t-PA) activity and total t-PA antigen levels in healthy control subjects differ from those in patients after myocardial infarction. Compared with healthy control subjects, patients studied 1-3 months after infarction had elevated levels of PAI-1 activity and fibrinogen but normal levels of C-reactive protein and von Willebrand factor antigen, whereas patients with a noncardiac acute-phase response showed elevation of all four proteins. Elevated PAI-1 activity in the absence of elevations in other acute-phase proteins suggests an intrinsic increase in PAI-1 secretion in the post-myocardial infarction group. In addition, when compared with healthy control subjects, post-myocardial infarction patients had higher levels of total t-PA antigen (bound and free t-PA) but lower t-PA activity and a lower percentage of active t-PA. Overall, survivors of myocardial infarction have reduced t-PA activity and increased PAI-1 activity that is not due to a prolonged acute-phase response.

摘要

本研究的目的是确定心肌梗死后纤溶酶原激活物抑制剂1(PAI-1)活性升高是反映基线PAI-1水平,还是代表梗死继发的急性期反应,并确定健康对照者的组织纤溶酶原激活物(t-PA)活性和总t-PA抗原水平与心肌梗死后患者的这些指标有何不同。与健康对照者相比,梗死1至3个月后接受研究的患者PAI-1活性和纤维蛋白原水平升高,但C反应蛋白和血管性血友病因子抗原水平正常,而有非心脏急性期反应的患者这四种蛋白均升高。在其他急性期蛋白未升高的情况下PAI-1活性升高,提示心肌梗死后组PAI-1分泌存在内在增加。此外,与健康对照者相比,心肌梗死后患者的总t-PA抗原(结合型和游离型t-PA)水平较高,但t-PA活性较低,活性t-PA的百分比也较低。总体而言,心肌梗死幸存者的t-PA活性降低,PAI-1活性升高,这并非由于急性期反应延长所致。

相似文献

1
Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.有心肌梗死病史患者的纤溶实验室评估。
Am J Clin Pathol. 1994 Aug;102(2):248-52. doi: 10.1093/ajcp/102.2.248.
2
Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.在斯德哥尔摩心脏流行病学项目(SHEEP)研究中,血浆组织型纤溶酶原激活剂/纤溶酶原激活剂抑制剂-1复合物水平和血管性血友病因子是复发性心肌梗死的重要风险标志物。
Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):2019-23. doi: 10.1161/01.atv.20.8.2019.
3
Alterations in the fibrinolytic system components during acute myocardial infarction.急性心肌梗死期间纤溶系统成分的改变。
Acta Cardiol. 2000 Aug;55(4):247-53. doi: 10.2143/AC.55.4.2005747.
4
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.1型纤溶酶原激活物抑制剂对缺血性心脏病患者组织型纤溶酶原激活物介导的纤维蛋白溶解的调节作用:利尿剂可能产生的不利影响。
Coron Artery Dis. 1994 Jul;5(7):617-23. doi: 10.1097/00019501-199407000-00010.
5
Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.心肌梗死糖尿病和非糖尿病幸存者中的纤溶酶原激活物抑制剂活性
Arterioscler Thromb. 1993 Mar;13(3):415-20. doi: 10.1161/01.atv.13.3.415.
6
Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death.心肌梗死亚急性期血浆纤溶因子浓度可预测心肌梗死复发或心源性猝死。
Int J Cardiol. 2002 Oct;85(2-3):277-83. doi: 10.1016/s0167-5273(02)00186-9.
7
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.长期使用血管紧张素转换酶抑制剂是否会影响既往心肌梗死患者血液中组织型纤溶酶原激活物-纤溶酶原激活物抑制剂-1的浓度。
Coron Artery Dis. 1997 May;8(5):283-91. doi: 10.1097/00019501-199705000-00005.
8
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.心绞痛患者血浆纤溶酶原激活物抑制剂-1。血浆胰岛素和急性期反应的影响。
Arteriosclerosis. 1989 May-Jun;9(3):362-7. doi: 10.1161/01.atv.9.3.362.
9
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.急性心肌梗死时血浆组织型纤溶酶原激活物及纤溶酶原激活物抑制剂-1水平
Pathophysiol Haemost Thromb. 2002 Mar-Apr;32(2):80-4. doi: 10.1159/000065080.
10
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction.PAI-1 活性和 t-PA 抗原水平升高与新发 ST 段抬高型心肌梗死患者葡萄糖调节异常有关。
J Thromb Haemost. 2011 Aug;9(8):1468-74. doi: 10.1111/j.1538-7836.2011.04377.x.